The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Mortality in Patients with Hemophilia: Changes in a Dutch Population from 1986 to 1992 and 1973 to 1986

Mattanja Triemstra, MSc; Frits R. Rosendaal, MD; Cees Smit, BA; Henk M. Van der Ploeg, PhD; and Ernest Briet, MD
[+] Article, Author, and Disclosure Information

From Vrije Universiteit, Amsterdam, the Netherlands; University Hospital Leiden, Leiden, the Netherlands; and the Netherlands Hemophilia Society, Badhoevedorp, the Netherlands. Acknowledgments: The authors thank the patients who participated in the ongoing national questionnaire survey on hemophilia, conducted for the fourth time in 1992; the Netherlands Hemophilia Society, the Dutch hemophilia treatment centers, and associated physicians for their help in compiling information on patients; Mrs. A.M.T. Borm and Mrs. W. Noteboom for clerical assistance in updating the patient registry and data entry; and Professor J.P. Vandenbroucke for his helpful comments on epidemiologic matters. Grant Support: By grant 28-2139 from Het Praeventiefonds, the Netherlands. Requests for Reprints: Frits R. Rosendaal, MD, Department of Clinical Epidemiology, University Hospital Leiden, Building 1, CO-P42, PO Box 9600, 2300 RC Leiden, the Netherlands. Current Author Addresses: Drs. Triemstra and Van der Ploeg: Department of Medical Psychology, Vrije Universiteit Amsterdam, Van der Boechorststraat 7, 1081 BT Amsterdam, the Netherlands.

Copyright ©2004 by the American College of Physicians

Ann Intern Med. 1995;123(11):823-827. doi:10.7326/0003-4819-123-11-199512010-00002
Text Size: A A A

Objective: To determine causes of death and mortality rates in patients with hemophilia over a period of 20 years, to assess changes in mortality, and to distinguish between hemophilia-related death and recent death induced by viral infections.

Design: Cohort study of 919 patients followed from January 1986 to June 1992. Results were compared with outcomes of previous follow-up from 1973 to 1986.

Setting: Consecutive national questionnaire surveys on hemophilia, using patient registries of the Netherlands Hemophilia Society and Dutch hemophilia centers.

Patients: 919 males with hemophilia A or B who participated in a national questionnaire survey on hemophilia in 1985. Median duration of follow-up was 6.4 years, which yielded 5753 person-years of follow-up. The mean age at study entry was 30 years (range, 1 to 85 years).

Measurements: Standardized mortality ratios, causes of death, median life expectancy, age-adjusted relative risks associated with the type or severity of hemophilia, presence of inhibitors, prophylaxis, and human immunodeficiency virus infection.

Results: 45 patients (5%) died between January 1986 and June 1992; 22.6 patients had been expected to die. Thus, the overall standardized mortality ratio was 2.0. The overall median life expectancy was 66 years for the cohort studied from 1973 to 1986 and 68 years for the cohort studied from 1986 to 1992. When deaths related to viral infection were excluded, the life expectancy almost equaled that of the general male population. Between 1986 and 1992, 1 patient died of ischemic heart disease compared with the 5.2 who were expected to die of this disease. Infection with HIV was the strongest independent predictor of death (relative risk, 27.5 [95% CI, 5.7 to 132.8]). After adjustment for HIV infection, no other hemophilia-related risk factors were associated with the risk for death.

Conclusions: The acquired immunodeficiency syndrome and hepatitis strongly influence mortality in patients with hemophilia. In the absence of viral infections, the life expectancy of patients with hemophilia would almost equal that of the general male population.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.